<DOC>
	<DOC>NCT01734447</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of this trial is to assess the safety of long-term growth hormone treatment in growth-retarded children with intrauterine growth retardation (IUGR) enrolled in trial GHRETARD/F/1/F.</brief_summary>
	<brief_title>Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation</brief_title>
	<detailed_description />
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<criteria>Patients born with IUGR enrolled in trial GHRETARD/F/1/F Bone age below 14 years in boys and 12 years in girls Bone age above 14 years in boys and 12 years in girls</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>